134 related articles for article (PubMed ID: 11754590)
1. Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffold.
Ohkanda J; Lockman JW; Kothare MA; Qian Y; Blaskovich MA; Sebti SM; Hamilton AD
J Med Chem; 2002 Jan; 45(1):177-88. PubMed ID: 11754590
[TBL] [Abstract][Full Text] [Related]
2. A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing.
Vogt A; Qian Y; Blaskovich MA; Fossum RD; Hamilton AD; Sebti SM
J Biol Chem; 1995 Jan; 270(2):660-4. PubMed ID: 7822292
[TBL] [Abstract][Full Text] [Related]
3. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.
Long SB; Hancock PJ; Kral AM; Hellinga HW; Beese LS
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12948-53. PubMed ID: 11687658
[TBL] [Abstract][Full Text] [Related]
5. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I.
Vasudevan A; Qian Y; Vogt A; Blaskovich MA; Ohkanda J; Sebti SM; Hamilton AD
J Med Chem; 1999 Apr; 42(8):1333-40. PubMed ID: 10212118
[TBL] [Abstract][Full Text] [Related]
6. Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferase.
Qian Y; Blaskovich MA; Saleem M; Seong CM; Wathen SP; Hamilton AD; Sebti SM
J Biol Chem; 1994 Apr; 269(17):12410-3. PubMed ID: 8175645
[TBL] [Abstract][Full Text] [Related]
7. N-Arylalkyl pseudopeptide inhibitors of farnesyltransferase.
deSolms SJ; Giuliani EA; Graham SL; Koblan KS; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Scholz TH; Wiscount CM; Gibbs JB; Smith RL
J Med Chem; 1998 Jul; 41(14):2651-6. PubMed ID: 9651171
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of type-I geranylgeranyltransferase in vitro and in whole cells by CAAL peptidomimetics.
Qian Y; Vogt A; Vasudevan A; Sebti SM; Hamilton AD
Bioorg Med Chem; 1998 Mar; 6(3):293-9. PubMed ID: 9568283
[TBL] [Abstract][Full Text] [Related]
9. Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase.
Curtin ML; Florjancic AS; Cohen J; Gu WZ; Frost DJ; Muchmore SW; Sham HL
Bioorg Med Chem Lett; 2003 Apr; 13(7):1367-71. PubMed ID: 12657284
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
[TBL] [Abstract][Full Text] [Related]
11. Cyclopropane-derived peptidomimetics. design, synthesis, and evaluation of novel Ras farnesyltransferase inhibitors.
Hillier MC; Davidson JP; Martin SF
J Org Chem; 2001 Mar; 66(5):1657-71. PubMed ID: 11262110
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.
Henry KJ; Wasicak J; Tasker AS; Cohen J; Ewing P; Mitten M; Larsen JJ; Kalvin DM; Swenson R; Ng SC; Saeed B; Cherian S; Sham H; Rosenberg SH
J Med Chem; 1999 Nov; 42(23):4844-52. PubMed ID: 10579847
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent inhibition of protein farnesyltransferase by a benzodiazepine peptide mimetic.
Roskoski R; Ritchie PA
Biochemistry; 2001 Aug; 40(31):9329-35. PubMed ID: 11478901
[TBL] [Abstract][Full Text] [Related]
15. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine.
Sun J; Blaskovich MA; Knowles D; Qian Y; Ohkanda J; Bailey RD; Hamilton AD; Sebti SM
Cancer Res; 1999 Oct; 59(19):4919-26. PubMed ID: 10519405
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; EtiƩvant C; Hill B
Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of hydroxyproline-derived isoprenyltransferase inhibitors.
O'Connell CE; Ackermann K; Rowell CA; Garcia AM; Lewis MD; Schwartz CE
Bioorg Med Chem Lett; 1999 Jul; 9(14):2095-100. PubMed ID: 10450988
[TBL] [Abstract][Full Text] [Related]
18. Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.
deSolms SJ; Ciccarone TM; MacTough SC; Shaw AW; Buser CA; Ellis-Hutchings M; Fernandes C; Hamilton KA; Huber HE; Kohl NE; Lobell RB; Robinson RG; Tsou NN; Walsh ES; Graham SL; Beese LS; Taylor JS
J Med Chem; 2003 Jul; 46(14):2973-84. PubMed ID: 12825937
[TBL] [Abstract][Full Text] [Related]
19. Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase.
Hunt JT; Lee VG; Leftheris K; Seizinger B; Carboni J; Mabus J; Ricca C; Yan N; Manne V
J Med Chem; 1996 Jan; 39(2):353-8. PubMed ID: 8558502
[TBL] [Abstract][Full Text] [Related]
20. Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.
Hunt JT; Ding CZ; Batorsky R; Bednarz M; Bhide R; Cho Y; Chong S; Chao S; Gullo-Brown J; Guo P; Kim SH; Lee FY; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Manne V
J Med Chem; 2000 Oct; 43(20):3587-95. PubMed ID: 11020273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]